Ketamine and Psilocybin Update in Treatment-Resistant Depression
Studies from Psych Congress 2022 show the efficacy of ketamine and psilocybin in reducing symptoms of treatment-resistant depression.
Source: psychiatryadvisor.com
Stay updated with breaking news from Remission Effectiveness. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Studies from Psych Congress 2022 show the efficacy of ketamine and psilocybin in reducing symptoms of treatment-resistant depression.